A long-term survivor keeping in a complete response without treatment after pemetrexed maintenance therapy for advanced non-squamous non-small cell lung cancer.
- Resource Type
- Report
- Authors
- Furugen M; Department of Infectious, Respiratory, and Digestive Medicine Graduate School of Medicine University of Ryukyus Okinawa Japan.; Shibahara D; Department of Infectious, Respiratory, and Digestive Medicine Graduate School of Medicine University of Ryukyus Okinawa Japan.; Kiyuna T; Department of Infectious, Respiratory, and Digestive Medicine Graduate School of Medicine University of Ryukyus Okinawa Japan.; Kami W; Department of Infectious, Respiratory, and Digestive Medicine Graduate School of Medicine University of Ryukyus Okinawa Japan.; Miyagi K; Department of Infectious, Respiratory, and Digestive Medicine Graduate School of Medicine University of Ryukyus Okinawa Japan.; Haranaga S; Department of Infectious, Respiratory, and Digestive Medicine Graduate School of Medicine University of Ryukyus Okinawa Japan.; Kubota T; Omoromachi Medical Center Hospital Okinawa Japan.; Matsumoto H; Department of Pathological Diagnosis Nakagami Hospital Okinawa Japan.; Yoshimi N; Department of Pathological Diagnosis Okinawa Red Cross Hospital Okinawa Japan.; Fujita J; Department of Infectious, Respiratory, and Digestive Medicine Graduate School of Medicine University of Ryukyus Okinawa Japan.
- Source
- Publisher: John Wiley & Sons Country of Publication: England NLM ID: 101620385 Publication Model: eCollection Cited Medium: Print ISSN: 2050-0904 (Print) Linking ISSN: 20500904 NLM ISO Abbreviation: Clin Case Rep Subsets: PubMed not MEDLINE
- Subject
- Language
- English
- ISSN
- 2050-0904
Pemetrexed has significant efficacy for some non-squamous non-small cell lung cancer cases, as demonstrated in the current case. For those patients, pemetrexed administration should be carefully considered.
Competing Interests: The authors have no conflicts of interest.
(© 2020 The Authors. Clinical Case Reports published by John Wiley & Sons Ltd.)